Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Zenflow has raised $24.0M in total funding. The most recent round was Series C. The last funding was announced in November 2024.
Zenflow's investors include National Science Foundation, Y Combinator, National Institutes of Health, Propel(X), F-Prime Capital.
Zenflow is headquartered in South San Francisco, United States.
Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Zenflow is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zenflow — Funding & Investors." VCBacked, November 18, 2024, https://www.vcbacked.co/company/zenflow. Accessed July 19, 2026.
VCBacked. (2024). Zenflow — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/zenflow
{{cite web |title=Zenflow — Funding & Investors |url=https://www.vcbacked.co/company/zenflow |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated